Labetalol hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H24N2O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1GEV3BAW9J, chemically known as benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)- but more generally known as labetalol hydrochloride, which bears US NIH Compound Identifier 3869. European Medicines Agency schedules Labetalol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02844MIG. Most nations, for tariff and trade purposes, schedule labetalol hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, LABETALOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Labetalol hydrochloride bears US NLM identifiers UMLS ID C0699440 and NCI Concept Code C63578. SMILES: CC(CCC1CCCCC1)NCC(C2CCC(C(C2)C(=O)N)O)O.CL.